Skip to content

Clinical trials

Phase 4 Lung Diseases trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Phase: Phase 4 Country / region: Canada Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20111
20121
20191
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
ActiViews Ltd.1
Bayer1
Drahomir Aujesky1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases6
Pulmonary Disease, Chronic Obstructive2
Asthma1
Bronchitis1
Bronchitis, Chronic1
Cardiovascular Diseases1
Cystic Fibrosis1
Embolism1
Embolism and Thrombosis1
Hemorrhage1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.